Where Global Innovation
and Capital Meet
Sectors Art of CVCConsumerEnergyFinancialHealthIndustrialITMediaServicesStartupsTelecomsTransportUniversity

Page 150

PMV veers toward $100m IPO

PMV Pharmaceuticals – built on foundational work at Princeton – will use some of the proceeds to complete phase 1 trials of its lead asset.

Sep 10, 2020

Grail to pour itself on to public markets

Illumina's cancer diagnostics spinoff, which has raised more than $1.9bn in funding, has filed to float on the Nasdaq Global Select Market.

Sep 10, 2020

Omnitracs to take SmartDrive in $450m deal

Wabco and Michelin North America are set to exit video telematics system developer SmartDrive, which has agreed to be purchased after raising at least $265m.

Sep 10, 2020

BacklotCars parks in KAR in $425m acquisition

KAR Auction Services has agreed to pay $425m to buy the online used vehicle marketplace, which had raised about $50m from investors including Renren.

Sep 9, 2020

Progress leads to $220m Chef acquisition

Progress intends to buy software development technology producer Chef for $220m in cash, following $105m in funding from backers including HPE and Citi.

Sep 9, 2020

Taboola and Outbrain forget planned merger

The agreed merger between corporate-backed digital advertisers Outbrain and Taboola has failed nearly a year after plans for a $850m deal were announced.

Sep 9, 2020

Yalla to yank itself to public markets

The SIG-backed, MENA-focused chatroom app developer has filed to raise up to $100m in an offering on the New York Stock Exchange.

Sep 9, 2020

Telefónica sweeps up iHackLabs

Telefónica-owned ElevenPaths has bought cybersecurity training service iHackLabs, which received funding from Telefónica's Wayra unit in 2018.

Sep 9, 2020

Alkahest aligns with Grifols for $146m acquisition

Grifols has acquired its existing portfolio company Alkahest, five years after buying a 45% stake in the Stanford University spinout.

Sep 8, 2020

Alkahest aligns with Grifols for $146m acquisition

Grifols agreed the deal five years after supplying $50m in equity and development financing for the neurodegenerative disease therapy developer.

Sep 8, 2020
© 2025 Mawsonia Ltd. All rights reserved.
test reg

Login

Not yet subscribed?

See your subscription offers here